MannKind

-$0.18 (-4.05%) Today

-$0.03 (-0.70%) As of 8:42 AM UTC after-hours

Why Robinhood?

You can buy or sell MannKind and other stocks, options, and ETFs commission-free!

About MNKD

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

CEO

Michael E. Castagna

Employees

241

Headquarters

Westlake Village, California

Founded

1991

MNKD Key Statistics

Market Cap

1.06B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

3.89M

High Today

$4.46

Low Today

$4.23

Open Price

$4.39

Volume

4.53M

52 Week High

$6.25

52 Week Low

$1.52

MNKD News

MarketWatchJun 16

MannKind Shares Rise 9% After Priority Review for Tyvaso DPI NDA

By Chris Wack MannKind Corp. shares were up 9% to $4.47 Wednesday after the U.S. Food and Drug Administration accepted for priority review the new drug applica

Analyst Ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

MNKD Earnings

-$0.08

-$0.05

-$0.03

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 4, After Hours